Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay.
about
Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathiesDiagnosis and classification of idiopathic inflammatory myopathies.Evaluation of antinuclear antibodies by indirect immunofluorescence and line immunoassay methods': four years' data from Turkey.Autoantibodies against a 43 KDa muscle protein in inclusion body myositisNovel autoantibodies and clinical phenotypes in adult and juvenile myositis.Analysis of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase using different technologies.Myositis autoantibodies and clinical phenotypes.Myositis-specific autoantibodies: detection and clinical associations.Significance of myositis autoantibody in patients with idiopathic interstitial lung diseaseSerological epitope profile of anti-Ro52-positive patients with systemic autoimmune rheumatic diseasesThe juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomesMyositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositisSingle-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations.Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.Cutting edge issues in polymyositis.Review: immune-mediated necrotizing myopathies--a heterogeneous group of diseases with specific myopathological features.Clinical guidelines and definitions of autoinflammatory diseases: contrasts and comparisons with autoimmunity-a comprehensive review.Rituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literature.Autoantibodies in polymyositis and dermatomyositis.Clinical heterogeneity and outcomes of antisynthetase syndrome.A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.Serological subsets of juvenile idiopathic inflammatory myopathies--an update.Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay.Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease.Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD).[New aspects on the pathogenesis of myositis].Pulmonary capillaritis in a patient with moderately positive anti-PL-12 antibodies.[Anti-synthetase syndrome: anti-PL-7, anti-PL-12 and anti-EJ].Reflex testing of speckled cytoplasmic patterns observed in routine ANA HEp-2 indirect immunofluorescence with a multiplex anti-synthetase dot-blot assay: a multicentric pilot study.The olfactory function is impaired in patients with idiopathic inflammatory myopathies.Autoantibody Specificities and Type I Interferon Pathway Activation in Idiopathic Inflammatory MyopathiesCamptocormia as a clinical manifestation of polymyositis/systemic sclerosis overlap myositis associated with anti-Ku
P2860
Q26863125-5F62FC14-634E-4044-AC86-228BBC8AD78AQ30249522-E1AF9918-B3B1-4142-80CE-3C624779D9A7Q30801548-8D35B814-FA04-4999-95FD-DBFFE5C58061Q33918389-FE43D1EF-68EA-4162-94F7-95F3F3A56561Q35092898-53506B23-8B94-4039-9D7F-3B98BF8AC745Q35151003-DBF816D3-B352-4F15-8551-5A673E46DE13Q35281962-18FF3CDD-4C48-4CDA-BD9E-E6BD2E3FA775Q35309808-3DD3BF22-344D-4FDE-9B19-FA1AEDC9277CQ35421571-44ECB6C9-A661-41E5-BD0E-3B35E2871E48Q36439998-6D71975B-617C-4878-B99F-42D230A3077BQ37022721-3EB34010-8C06-442E-B6D2-307C009049C8Q37023594-78A13EC4-2C80-49F9-B6B1-285381E9A0B8Q37226360-90841260-3847-41FF-9AFE-43EB20785A78Q37674765-14EBE6F2-3058-4747-825D-1DEB6CFC8948Q37824617-62EF8E7D-7822-49EB-98BD-E26635091DFDQ38044467-26C652FB-9124-4269-9B0F-1BE0E46B8969Q38074354-9FB371EA-5D0A-48A8-B344-D7EDF5429372Q38097748-A293EC53-ECE5-4E18-B109-BE8A506C83BDQ38099556-F9799926-1681-4ED7-AA51-780BB153E1E1Q38116464-6223B98E-D58A-43DD-B27D-074296061234Q38596370-32D5BB39-B13A-4A65-A1DC-DC59CFDFE738Q38646384-19B16896-313D-4777-9753-5A75915BCB3FQ38664251-7734A282-F50A-4963-81C1-9FF3B8EDAC2CQ38851103-255EA654-02F0-4DEC-92FF-9014DF488CE4Q38851108-0EA2B138-AF74-4A88-9156-D017409172D1Q40747808-5A4E32A0-B970-43AF-9D66-B64A33FB619FQ41538311-3BD34059-2CDA-47B6-9040-B06AAEF028CFQ43978656-818B3928-6454-4686-BD91-FB3CBF2D8463Q46251852-39D9A41A-D7C5-4BF6-80F4-A5729C25EA13Q46504106-1953FD3D-6181-4DDF-AE13-0905E3DDC324Q47437750-64A2A296-F3EE-4D20-9098-48A7CE08F2F1Q48176876-B778DA44-D50A-43C6-AEDC-3F3676C08C86Q57536946-E2331EB7-274A-4F62-A967-B7B4F1DD52E5Q57756382-856FA29A-346A-40C2-80B1-9CE2BBE669E0
P2860
Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Diagnostic performance and val ...... a commercial line blot assay.
@en
Diagnostic performance and val ...... a commercial line blot assay.
@nl
type
label
Diagnostic performance and val ...... a commercial line blot assay.
@en
Diagnostic performance and val ...... a commercial line blot assay.
@nl
prefLabel
Diagnostic performance and val ...... a commercial line blot assay.
@en
Diagnostic performance and val ...... a commercial line blot assay.
@nl
P2093
P2860
P50
P356
P1433
P1476
Diagnostic performance and val ...... a commercial line blot assay.
@en
P2093
Anna Ghirardello
Elena Tarricone
Louise Ekholm
Margherita Zen
Mariaelisa Rampudda
Nicola Bassi
Sandra Zampieri
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEQ281
P577
2010-08-19T00:00:00Z